3

PRIMARY DOCUMENT

Company: PALVELLA THERAPEUTICS, INC.
Filed: March 23, 2020
Period of Report: March 12, 2020
Accession Number: 0001591986-20-000008

View Document ↗ View on SEC.gov ↗